MBP-8298
a synthetic peptide analog of myelin basic protein for the treatment of multiple sclerosis
Also Known As:
Dirucotide; L-alpha-aspartyl-L-alpha-glutamyl-L-asparaginyl-L-prolyl-L-valyl-L-valyl-L-histidyl-L-phenylalanyl-L-phenylalanyl-L-lysyl-L-asparaginyl-L-isoleucyl-L-valyl-L-threonyl-L-prolyl-L-arginyl-L-threonine; MBP8298
Networked: 6
relevant articles (0 outcomes,
2 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Apostolopoulos, Vasso:
1 article
(12/2018)
|
2. | Christopoulou, Konstantina:
1 article
(12/2018)
|
3. | Deraos, George:
1 article
(12/2018)
|
4. | Kalbacher, Hubert:
1 article
(12/2018)
|
5. | Kritsi, Eftichia:
1 article
(12/2018)
|
6. | Matsoukas, John:
1 article
(12/2018)
|
7. | Matsoukas, Minos-Timotheos:
1 article
(12/2018)
|
8. | Zoumpoulakis, Panagiotis:
1 article
(12/2018)
|
9. | Boudesocque, Leslie:
1 article
(09/2017)
|
10. | Forni, Luciano:
1 article
(09/2017)
|
Related Diseases
Related Drugs and Biologics